ClinicalTrials.gg
CompletedNCT07881289ABVN2Updated Oct 19, 2026

ABVN Phase 2 - Vagal Maneuvers

An interventional study of Vagal Maneuvers in Gastroparesis, sponsored by Indiana University. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Indiana University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 5 years 10 months after the study started (first participant enrolled Nov 2020, registered Oct 2026).
Updated Oct 19, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Not applicable
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The vagus nerve is a nerve that controls many bodily functions, including stomach function. Investigators want to evaluate the effects of noninvasive stimulation of the auricular branch of the vagal nerve (ABVN) on vagal nerve function.

The purpose of the ABVN Phase 2 grant is to expand on previous work evaluating vagally mediated compound nerve action potentials (CNAPs). This will be accomplished through several independent, but related, studies. In this study, investigators will evaluate the effect of vagal stimulation through simple physical techniques (vagal maneuvers) in subjects with gastroparesis.

[This study was originally described in NCT06491758, however a separate record has been created to more accurately reflect the independence of the individual studies supported by the ABVN 2 grant.]

Read the detailed description

Patients with gastroparesis will be recruited for this project, which is expected be completed over approximately 3 hours. If all procedures cannot be completed in a single visit, participants may return on a second day to complete them.

When participants arrive, electrodes are placed over the right and left vagus nerve (to record vagal nerve activity), chest (to record electrocardiogram, or ECG) and stomach area (to record electrogastogram, or EGG). A 10 minute baseline recording of vagal nerve activity, electrocardiogram (ECG) and electrogastrogram (EGG) is then completed prior to beginning the vagal maneuvers.

Participants may be asked to perform any of the following maneuvers:

  • Cough: Each subject will be asked to generate approximately 6 to 8 forceful and sustained coughs over 5 to 10 seconds.
  • Cold stimulus to face: An ice pack or a washcloth soaked in ice water will be placed on each subject's face for about 10 seconds to mimic the physiological response of being submerged in cold water (Diver's Reflex)
  • Carotid Massage: This technique is performed with the subject's neck in an extended position with the head turned away from the side being massaged. Only one side is massaged at a time. Pressure is applied underneath the angle of the jaw in a gentle circular motion for about 10 seconds. The subject is monitored throughout.
  • Gagging: A tongue depressor is briefly inserted into the subject's mouth touching the back of the throat, which causes the person to reflexively gag.
  • Valsalva maneuver: The subject is instructed to bear down as if they were having a bowel movement. The subject is asked to blow through a mouthpiece that is hooked to a device used in clinical spirometry until the pressure reaches 10mmHg.Alternatively, we can have the subject blow through the barrel of a 10 ml syringe for 15-20 seconds. This maneuver increases intrathoracic pressure and stimulates the vagus nerve.

After performing a maneuver for 10 seconds, another 8 minutes of recording will be made before doing any additional maneuvers.

Participants may also be asked to perform one or more eating maneuvers after an overnight fast.

  • Eating: After 20 minutes of baseline recordings, subjects will be asked to drink 8 ounces of either water or Ensure Original. After the fluid is consumed, an additional 20 minutes of recordings will be made.

Maneuvers will be selected at the investigator's discretion and not all maneuvers will be completed. If both the water and Ensure eating maneuvers are selected, they will be completed at two separate visits.

02

Conditions studied

  • Gastroparesis

Browse trials for

03

In context

Gastroparesis

311 studies on the registry are indexed under Gastroparesis; 67 are open to participants now.

This study's enrollment of 33 is below the median of 42 across 205 interventional studies indexed under Gastroparesis.

Browse Gastroparesis studies →

Lead sponsor

Indiana University is the lead sponsor of 982 studies on the registry; 199 are open to participants now.

Of its 148 completed or terminated interventional studies of FDA-regulated products, 117 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Have a formal diagnosis of gastroparesis or are seeing the GI physician for symptoms related to gastroparesis
  • Aged 18-80 years
  • Willing to perform vagal activity maneuver (Vagal arm)

Exclusion criteria

Exclusion Criteria:

  • Have an implanted gastric stimulator
  • Unable to provide consent
  • Pregnant females
  • Prisoners
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
33 participants (actual)

Study arms

  • Experimental
    Gastroparesis Subjects

    Subjects with a confirmed diagnosis of gastroparesis.

    Other: Vagal Maneuvers

Interventions

  • OtherVagal Maneuvers

    Subjects will be asked to perform various maneuvers to stimulate the vagus nerve: * Cough: Produce 6 to 8 forceful coughs over 5 to 10 seconds * Cold stimulus to face: Have an ice cold washcloth placed on their face for 10 seconds. * Carotid massage: While the neck is extended and the head turned away from the side being massaged, pressure is applied underneath the angle of the jaw in a gentle circular motion for about 10 seconds. * Gagging: a tongue depressor is briefly inserted into the mouth touching the back of the throat. * Valsalva maneuver: subjects will will be asked to bear down as if they were having a bowel movement. They will be asked to blow through a mouthpiece that is hooked to a machine that measures how hard they are blowing. Alternatively, they can blow through the barrel of a 10 ml syringe for 15-20 seconds. * Eating: Subjects will be asked to drink 8 ounces of water and/or Ensure Original after fasting overnight

06

What researchers measure

Primary outcomes

  1. Amplitude of vagal nerve compound action

    To measure the amplitude of vagal nerve compound action potentials during vagal maneuvers.

    Time frame: 3 hours

  2. Respiratory Changes in heart rate during stimulation

    To measure respiratory changes in heart rate during vagal maneuvers.

    Time frame: 3 hours

  3. Changes in amplitude of the surface electrogastrogram

    To measure the changes of surface electrogastogram during vagal maneuvers.

    Time frame: 3 hours

07

Study locations

1 site
  • Indiana University
    Indianapolis, Indiana 46202, United States
08

References and documents

Individual participant data

Plan to share: Yes — De-identified data may be shared with other researchers for similar purposes as to this study

Supporting information: Clinical study report, Analytic code

Time frame: Three years after study completion

Access criteria: None as of yet.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07881289
Lead sponsor
Indiana University
Responsible party
Thomas V. Nowak (Professor, Indiana University) — Principal investigator
First posted
Oct 19, 2026
Start date
Nov 24, 2020
Primary completion
Mar 25, 2022
Completion
Mar 25, 2022
Last update
Oct 19, 2026

Study contacts

Thomas V Nowak, MD
principal investigator · Indiana University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion